Temozolomide-Capecitabine (TemCap) chemotherapy for Neuroendocrine Neoplasms (NENs): the dilemma of treatment duration

Angela Lamarca; Jorge Barriuso; Mairéad G. Mcnamara; Richard A. Hubner; Prakash Manoharan; Wasat Mansoor; Juan W. Valle

doi:10.1159/000503392

Temozolomide-Capecitabine (TemCap) chemotherapy for Neuroendocrine Neoplasms (NENs): the dilemma of treatment duration

Angela Lamarca, Jorge Barriuso, Mairéad G. Mcnamara, Richard A. Hubner, Prakash Manoharan, Wasat Mansoor, Juan W. Valle

Research output: Contribution to journal › Letter › peer-review

72 Downloads (Pure)

Original language	English
Journal	Neuroendocrinology
Early online date	17 Sept 2019
DOIs	https://doi.org/10.1159/000503392
Publication status	Published - 2019

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000503392

2019-09-19-TemCap letter - FINAL (003)Accepted author manuscript, 227 KB

https://www.karger.com/Article/FullText/503392

Cite this

@article{0694bcba669843bda79bfc0821be2d08,

title = "Temozolomide-Capecitabine (TemCap) chemotherapy for Neuroendocrine Neoplasms (NENs): the dilemma of treatment duration",

author = "Angela Lamarca and Jorge Barriuso and Mcnamara, {Mair{\'e}ad G.} and Hubner, {Richard A.} and Prakash Manoharan and Wasat Mansoor and Valle, {Juan W.}",

year = "2019",

doi = "10.1159/000503392",

language = "English",

journal = "Neuroendocrinology",

issn = "0028-3835",

publisher = "S. Karger AG",

}

TY - JOUR

T1 - Temozolomide-Capecitabine (TemCap) chemotherapy for Neuroendocrine Neoplasms (NENs): the dilemma of treatment duration

AU - Lamarca, Angela

AU - Barriuso, Jorge

AU - Mcnamara, Mairéad G.

AU - Hubner, Richard A.

AU - Manoharan, Prakash

AU - Mansoor, Wasat

AU - Valle, Juan W.

PY - 2019

Y1 - 2019

U2 - 10.1159/000503392

DO - 10.1159/000503392

M3 - Letter

SN - 0028-3835

JO - Neuroendocrinology

JF - Neuroendocrinology

ER -